SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001178913-23-002832
Filing Date
2023-08-11
Accepted
2023-08-11 16:16:36
Documents
14
Period of Report
2023-08-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K zk2330154.htm   iXBRL 8-K 30512
2 EXHIBIT 99.1 exhibit_99-1.htm EX-99.1 103591
6 image0.jpg GRAPHIC 4528
  Complete submission text file 0001178913-23-002832.txt   293278

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA entx-20230811.xsd EX-101.SCH 3868
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE entx-20230811_lab.xml EX-101.LAB 23290
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE entx-20230811_pre.xml EX-101.PRE 16554
8 EXTRACTED XBRL INSTANCE DOCUMENT zk2330154_htm.xml XML 4387
Mailing Address KIRYAT HADASSAH, MINRAV BUILDING FIFTH FLOOR JERUSALEM L3 9112002
Business Address KIRYAT HADASSAH, MINRAV BUILDING FIFTH FLOOR JERUSALEM L3 9112002 972-2-532-7151
Entera Bio Ltd. (Filer) CIK: 0001638097 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38556 | Film No.: 231164343
SIC: 2836 Biological Products, (No Diagnostic Substances)